Search

Displaying results 6771 - 6780 of 10000 in total
  1. Indication

    Tongue inflammation

    go.drugbank.com/conditions/DBCOND0134841
    Drugs: Benzethonium · Chlorhexidine · Dequalinium · Tyrothricin
    Synonyms: Glossitis, NOS, Glossitis NOS (disorder)
  2. Drug

    Butropium

    go.drugbank.com/drugs/DB15968
    Experimental

  3. Indication

    Ulcers

    go.drugbank.com/conditions/DBCOND0032524
    Drugs: Beraprost · Nepidermin · Sulfamerazine · Sulfamethazine
    Synonyms: Ulcer NOS, Ulcer, NOS
  4. Drug

    Cry5B

    go.drugbank.com/drugs/DB17783
    Experimental

    Cry5B is a pore-forming crystal protein produced by and derived from the soil bacterium _Bacillus thuringiensis_.

  5. Drug

    AZD-8186

    go.drugbank.com/drugs/DB15029
    Investigational

    investigation in clinical trial NCT03218826 (PI3Kbeta Inhibitor AZD8186 and Docetaxel in Treating Patients Advanced Solid Tumors With PTEN or PIK3CB Mutations That Are Metastatic or Cannot Be Removed by

  6. Drug

    2X-121

    go.drugbank.com/drugs/DB16063
    Investigational

    2X-121 is under investigation in clinical trial NCT03562832 (Investigation of Anti-tumour Effect and Tolerability of the PARP Inhibitor 2X-121 in Patients With Metastatic Breast Cancer Selected by the

  7. Indication

    Lung Cancer, Nonsmall Cell, Stage IIIA

    go.drugbank.com/conditions/DBCOND0150709
    Drugs: Atezolizumab · Gemcitabine · Pembrolizumab
    Synonyms: Non-small Cell Lung Cancer Stage IIIA, IIIA Stage Non-small Cell Lung Cancer
  8. Drug

    Platelet Lysate

    go.drugbank.com/drugs/DB15869
    Investigational

    Because white cell antigens are low in prepared lysate, there is a minimized likelihood of immune responses.

  9. Drug

    Aptazapine

    go.drugbank.com/drugs/DB09305
    Experimental

    It antagonised α2 adrenergic receptors approximately 10 times more effectively than mianserin, antagonised 5-HT2 receptors, agonised H1 receptors, and did not affect reuptake of serotonin or norepinephrine

  10. Drug

    Desmethylprodine

    go.drugbank.com/drugs/DB01478
    ExperimentalIllicit

    It has been listed as a Schedule I controlled drug in the United States, and thus is not used clinically. It is known to be a designer drug, synthesized in 1977, for the purpose of recreational use.